These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 7514324)

  • 21. [Anti-HCV serology for screening, diagnosis and surveillance of hepatitis C: role of the immunoblot].
    Dubois F; Barin F; Goudeau A
    Ann Biol Clin (Paris); 1998; 56(4):417-26. PubMed ID: 9754277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen.
    Lavanchy D; Mayerat C; Morel B; Schneider P; Zufferey C; Gonvers JJ; Pécoud A; Frei PC
    J Clin Microbiol; 1994 Sep; 32(9):2272-5. PubMed ID: 7529253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C viraemia in United Kingdom blood donors. A multicentre study.
    Garson JA; Clewley JP; Simmonds P; Zhang LQ; Mori J; Ring C; Follett EA; Dow BC; Martin S; Gunson H
    Vox Sang; 1992; 62(4):218-23. PubMed ID: 1322612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
    Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
    Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
    Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
    J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population.
    MacDonald KL; Mills WA; Wood RC; Hanson M; Kline W; Bowman RJ; Polesky HF; Williams AE; Osterholm MT
    Transfusion; 1994 Mar; 34(3):202-8. PubMed ID: 8146891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
    Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
    Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of third-generation confirmatory tests for detection of antibody to hepatitis C virus.
    Chaudhary RK; Jacobsen H
    J Clin Microbiol; 1994 Oct; 32(10):2606-8. PubMed ID: 7529244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.
    Attia MA; Zekri AR; Goudsmit J; Boom R; Khaled HM; Mansour MT; de Wolf F; el-Din HM; Sol CJ
    J Clin Microbiol; 1996 Nov; 34(11):2665-9. PubMed ID: 8897161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
    Cavazza S; Lagging M
    Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study on reliability of commercially available hepatitis C virus antibody tests.
    Feucht HH; Zöllner B; Polywka S; Laufs R
    J Clin Microbiol; 1995 Mar; 33(3):620-4. PubMed ID: 7751366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
    Pawlotsky JM; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
    J Clin Microbiol; 1994 May; 32(5):1357-9. PubMed ID: 7519631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New-generation RIBA hepatitis C strip immunoblot assays.
    Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
    Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.
    Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M
    Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
    Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
    Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interpretation of Ortho HCV Ab ELISA test results by chiron HCV recombinant immunoblot assay].
    Yahagi N; Kitsugi K
    Rinsho Byori; 1991 Jan; 39(1):26-33. PubMed ID: 1848912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
    Chien DY; Choo QL; Tabrizi A; Kuo C; McFarland J; Berger K; Lee C; Shuster JR; Nguyen T; Moyer DL
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10011-5. PubMed ID: 1279666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups and blood donors. Viral Hepatitis and AIDS Study Group.
    Andreu J; Abad MA; Sanchez-Quijano A; Torronteras R; Luque F; Garcia de las Heras J; Soto B; Pineda JA; Leal M; Lissen E
    J Intern Med; 1994 Jul; 236(1):73-7. PubMed ID: 7517430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
    Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
    Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.